Paradoxical severe decrease in serum HDL-cholesterol after treatment with a fibrate: reply by the authors

被引:1
作者
Crook, M [1 ]
Lynas, J [1 ]
Wray, R [1 ]
机构
[1] Guys Hosp, Dept Chem Pathol, London SE1 9RT, England
关键词
D O I
10.1136/jcp.55.12.976
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
引用
收藏
页码:976 / 976
页数:1
相关论文
共 4 条
  • [1] A paradoxical severe decrease in serum HDL-cholesterol after treatment with a fibrate
    Crook, MA
    Lynas, J
    Wray, R
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2000, 53 (10) : 796 - 797
  • [3] Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
    Rubins, HB
    Robins, SJ
    Collins, D
    Fye, CL
    Anderson, JW
    Elam, MB
    Faas, FH
    Linares, E
    Schaefer, EJ
    Schectman, G
    Wilt, TJ
    Wittes, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (06) : 410 - 418
  • [4] Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease - The bezafibrate infarction prevention (BIP) study
    Schlesinger, Z
    Vered, Z
    Friedenson, A
    Reisin, L
    Jafari, J
    Flieb, T
    Sclarovsky, S
    Friedman, Y
    Ostfeld, B
    Solodky, A
    Abinader, E
    Rochfleish, S
    Palant, A
    Schneider, H
    Rosenfeld, T
    Khalid, S
    Wolfson, E
    Kishon, Y
    Narinsky, R
    Rotzak, R
    Davidov, A
    Levine, G
    Zahavi, I
    Vitrai, J
    Diker, D
    Pelled, B
    Pardu, J
    Galamidi, J
    Majadla, R
    Laniado, S
    Sherf, L
    Braun, S
    Eschar, Y
    Caspi, A
    Arditi, A
    Botwin, S
    Arkavi, L
    Ziv, M
    David, D
    Weisenberg, D
    Kohanovski, M
    Meisel, S
    Rougin, N
    Yahalom, M
    Glusman-Vazan, A
    Markiewitz, W
    Motlak, D
    Lessick, J
    Kagan, G
    Marmour, A
    [J]. CIRCULATION, 2000, 102 (01) : 21 - 27